EUVIMEDEUVIMED entdecken
Crossref

BIOCOMPATIBILITY OF C60 FULLERENE WITH THE HEMOSTATIC SYSTEM

V.O. Chernyshenko

Biotechnologia Acta · 30.04.2026 · 19 (3) · 77-89

DOI: 10.15407/biotech19.03.077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnologia Acta, online erschienen am 30.04.2026. Verfasst von V.O. Chernyshenko. Die Arbeit nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular compounds containing allotropic forms of carbon are intensively studied in various areas of science, such as nanobiotechnology, biomedicine, and pharmacology, for their practical application prospects. The most well-known carbon-based nanoparticles are the fullerene C60, a spherical cage with distinctive physical, chemical, and biological characteristics (stability, biocompatibility, and antioxidant, antitumor, and photosensitizing properties). However, understanding the mechanisms by which these particles influence the body's regulatory and integral systems is necessary to prevent potential human health risks in clinical practice.

Aim

The impact of fullerene C60 on the cardiovascular system was examined, with particular focus on hemostasis, to assess its safety for biomedical applications.

Methods

The study focused on the platelet, coagulation, anticoagulation, and fibrinolysis pathways of hemostasis.

Results

Research indicates that fullerene C60 at therapeutic doses of 0.1 μM and 1.0 μM does not affect the functional activity, shape, or granularity of human platelets during co-cultivation. When present, measurements such as PTT, APTT, thrombin activity, factor Xa, plasma protein C, and the overall hemostatic potential of blood plasma remain stable.

Conclusions

Fullerene C60 may be used in clinical settings as a bioinert carrier that interacts with blood at therapeutic doses without affecting or activating the hemostatic system.

Zitieren

APA

Chernyshenko, V. (2026). BIOCOMPATIBILITY OF C60 FULLERENE WITH THE HEMOSTATIC SYSTEM. Biotechnologia Acta, 19(3), 77-89. https://doi.org/10.15407/biotech19.03.077

Vancouver

Chernyshenko V. BIOCOMPATIBILITY OF C60 FULLERENE WITH THE HEMOSTATIC SYSTEM. Biotechnologia Acta. 2026;19(3):77-89. doi:10.15407/biotech19.03.077

BibTeX
@article{Chernyshenko2026,
  author = {Chernyshenko, V.O.},
  title = {BIOCOMPATIBILITY OF C60 FULLERENE WITH THE HEMOSTATIC SYSTEM},
  journal = {Biotechnologia Acta},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {77--89},
  doi = {10.15407/biotech19.03.077}
}
Kostenlos starten →